Fortitude Family Office, LLC
Family OfficePosition in INCY — Incyte Corp
CIK 1950506
SCOTTSDALE, AZ
Position in INCY
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$9,506
+$3,877 QoQ
Shares Held
101
+77.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fortitude Family Office, LLC holds $460,072 across 122 Biotechnology names. INCY ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
522 | $172,714 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
75 | $33,490 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
296 | $28,786 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25 | $19,316 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
60 | $11,343 | |
| 6 | CMPX |
Compass Therapeutics, Inc.
|
1,915 | $10,130 | |
| 7 | TERN |
Terns Pharmaceuticals, Inc.
|
192 | $10,122 | |
| 8 | INCY |
Incyte Corp
This page
|
101 | $9,506 |
All Filings in INCY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,506 | 101 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $5,629 | 57 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $4,494 | 53 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $3,609 | 53 | Shares | Sole | 2025-07-15 | |
| 2024-03-31 | $4,272 | 75 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $4,709 | 75 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||